<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Dobrijevic D</submitter><funding>Biotechnology and Biological Sciences Research Council</funding><funding>Engineering and Physical Sciences Research Council</funding><pagination>36608-36614</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9075147</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(63)</volume><pubmed_abstract>Ene-reductases (ERs) of the Old Yellow Enzyme family catalyse asymmetric reduction of activated alkenes providing chiral products. They have become an important method in the synthetic chemists' toolbox offering a sustainable alternative to metal-catalysed asymmetric reduction. Development of new biocatalytic alkene reduction routes, however needs easy access to novel biocatalysts. A sequence-based functional metagenomic approach was used to identify novel ERs from a drain metagenome. From the ten putative ER enzymes initially identified, eight exhibited activities towards widely accepted mono-cyclic substrates with several of the ERs giving high reaction yields and stereoselectivities. Two highly performing enzymes that displayed excellent co-solvent tolerance were used for the stereoselective reduction of sterically challenging bicyclic enones where the reactions proceeded in high yields, which is unprecedented to date with wild-type ERs. On a preparative enzymatic scale, reductions of Hajos-Parish, Wieland-Miescher derivatives and a tricyclic ketone proceeded with good to excellent yields.</pubmed_abstract><journal>RSC advances</journal><pubmed_title>Metagenomic ene-reductases for the bioreduction of sterically challenging enones.</pubmed_title><pmcid>PMC9075147</pmcid><funding_grant_id>BB/N01877X/1</funding_grant_id><funding_grant_id>EP/K005030/1</funding_grant_id><funding_grant_id>EP/P020410/1</funding_grant_id><funding_grant_id>BB/L007444/1</funding_grant_id><pubmed_authors>Dobrijevic D</pubmed_authors><pubmed_authors>Dawson N</pubmed_authors><pubmed_authors>Mendez-Sanchez D</pubmed_authors><pubmed_authors>Tappertzhofen N</pubmed_authors><pubmed_authors>Orengo CA</pubmed_authors><pubmed_authors>Benhamou L</pubmed_authors><pubmed_authors>Aliev AE</pubmed_authors><pubmed_authors>Moody TS</pubmed_authors><pubmed_authors>Baud D</pubmed_authors><pubmed_authors>Hailes HC</pubmed_authors><pubmed_authors>Ward JM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Metagenomic ene-reductases for the bioreduction of sterically challenging enones.</name><description>Ene-reductases (ERs) of the Old Yellow Enzyme family catalyse asymmetric reduction of activated alkenes providing chiral products. They have become an important method in the synthetic chemists' toolbox offering a sustainable alternative to metal-catalysed asymmetric reduction. Development of new biocatalytic alkene reduction routes, however needs easy access to novel biocatalysts. A sequence-based functional metagenomic approach was used to identify novel ERs from a drain metagenome. From the ten putative ER enzymes initially identified, eight exhibited activities towards widely accepted mono-cyclic substrates with several of the ERs giving high reaction yields and stereoselectivities. Two highly performing enzymes that displayed excellent co-solvent tolerance were used for the stereoselective reduction of sterically challenging bicyclic enones where the reactions proceeded in high yields, which is unprecedented to date with wild-type ERs. On a preparative enzymatic scale, reductions of Hajos-Parish, Wieland-Miescher derivatives and a tricyclic ketone proceeded with good to excellent yields.</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Nov</publication><modification>2026-05-30T20:53:20.417Z</modification><creation>2025-04-04T10:02:09.076Z</creation></dates><accession>S-EPMC9075147</accession><cross_references><pubmed>35539044</pubmed><doi>10.1039/c9ra06088j</doi></cross_references></HashMap>